definiens: shall mean:1.27.1 a single pharmaceutical formulation containing as its active ingredients both ( i ) a Protein Degrader or a Protein DegraderComponent and ( ii ) one or more other therapeutically or prophylactically active ingredients,1.27.2 a combination therapy comprised of ( i ) a Protein Degrader or a Protein Degrader Component and ( ii ) one or more othertherapeutically or prophylactically active products, priced and sold in a single package containing such multiple products or packagedseparately but sold together for a single price, or1.27.3 a combination therapy comprised of ( i ) a Protein Degrader or a Protein Degrader Component and ( ii ) a CompanionDiagnostic, priced and sold in a single package containing such multiple products or packaged separately but sold together for a single price, in each case, including all dosage forms, formulations, presentations, line extensions, and package configurations . All references toCollaboration Product in this Agreement shall be deemed to include Combination Product